Home | Samumed

SAMUMED NEWS

VIEW ALL

Samumed Announces Publication of Preclinical Data Demonstrating That SM07883 is a Potential Treatment for Alzheimer’s Disease Learn More

Samumed Doses First Subject in Phase 3 STRIDES-X-ray Trial of Lorecivivint for the Treatment of Knee Osteoarthritis Learn More

ABOUT SAMUMED

Pipeline

Publications

Company

Team

Technology

web stats